IDSA guideline strongly recommends age-appropriate RSV vaccination for adults and adolescents with compromised immunity; two test-negative studies showed vaccination reduced RSV hospitalisation by 70% (95% CI 66%-73%). Shared decision-making is advised under 18.
Guideline
Tan et al. IDSA 2025 Guidelines on the Use of Vaccines for the Prevention of Seasonal RSV Infections in Immunocompromised Patients